Mongodb Inc vs 10X Genomics Inc — how do they compare? Mongodb Inc trades at $435.19 (market cap $35.32B), while 10X Genomics Inc trades at $58.7 (market cap $7.61B). The key difference: Mongodb Inc is far larger — about 4.6× 10X Genomics Inc's market cap. Which is the better fit depends on your goals.
| MDB | TXG | |
|---|---|---|
Market Cap | $35.32B | $7.61B |
Sector | Technology | Health |
52-Week High | $440.25 | $58.57 |
52-Week Low | $204.37 | $11.34 |
Enterprise Value | $32.93B | $7.14B |
Trailing returns across standard periods
Founded in 2007, MongoDB is a document-oriented database with nearly 33,000 paying customers and well past 1.5 million free users. MongoDB provides both licenses as well as subscriptions as a service for its NoSQL database. MongoDB's database is compatible with all major programming languages and is capable of being deployed for a variety of use cases.
Read more on MDB →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →